FitBiomics

FitBiomics™ is a sports biotechnology company located in New York, New York. The company employs 13 individuals and generates an annual revenue of $2.5 million. FitBiomics™ specializes in utilizing next-generation sequencing to study the microbiomes of elite athletes. Their primary focus is identifying and isolating novel probiotic bacteria with the potential to enhance sports performance and recovery. These unique probiotics are then purified and commercialized as ingredients for the sports nutrition market, aiming to meet the needs of the evolving athletic landscape. The company distinguishes itself through its innovative approach, leveraging scientific research from its origins at the Wyss Institute for Biologically Inspired Engineering at Harvard University. Their work focuses on uncovering the specific microbial factors that contribute to athletic success, offering a cutting-edge solution for athletes seeking to optimize their performance. For more information about FitBiomics™ and their groundbreaking research, please visit their website at fitbiomics.com.